Related Experiment Videos

The need for tighter control of cardiovascular risk factors in diabetic patients

Giancarlo Viberti1

  • 1Unit for Metabolic Medicine, Guy's Hospital, Kings College London, London, UK.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|May 29, 2003
PubMed

Insights

Diabetic patients face higher risks of heart disease and stroke due to elevated blood glucose, lipids, and blood pressure. Tighter control of these cardiovascular risk factors is crucial for better patient outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Nephrology

Background:

  • Diabetic patients exhibit a 2-4 fold increased risk of macrovascular disease, with coronary heart disease (CHD) and stroke as leading causes of mortality in type 2 diabetes.
  • Diabetic nephropathy is a primary cause of end-stage renal disease in industrialized nations.
  • Hyperglycemia, dyslipidemia, and hypertension frequently coexist in diabetic individuals, exacerbating cardiovascular and renal risks.

Purpose of the Study:

  • To emphasize the critical need for enhanced control of cardiovascular risk factors in diabetic patients.
  • To highlight the link between specific risk factors and adverse outcomes in diabetes.
  • To advocate for the translation of clinical trial findings into routine clinical practice.

Main Methods:

  • Analysis of data from a meta-analysis of over 90,000 patients with a 12.4-year follow-up.
  • Review of findings from established trials like the Multiple Risk Factor Intervention Trial (MRFIT) and the United Kingdom Prospective Diabetes Study (UKPDS).
  • Examination of the relationship between blood glucose, cholesterol levels, blood pressure, and cardiovascular events.

Main Results:

  • A continuous increase in morbidity and mortality risks correlates with rising blood glucose concentrations.
  • Low-density lipoprotein cholesterol elevation by 1 mmol/l in type 2 diabetes increases CHD risk by 1.57.
  • Approximately 40% of newly diagnosed diabetics are hypertensive, with over 70% of hypertensive diabetics showing left ventricular hypertrophy (LVH).

Conclusions:

  • Tighter control of cardiovascular risk factors, including blood pressure, lipids, and glucose, is essential in diabetic patients.
  • Monitoring for left ventricular hypertrophy and microalbuminuria is recommended.
  • Clinical trial evidence supporting risk factor management in diabetes needs to be integrated into daily practice.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...